A 46-year-old man is currently enrolled in a Phase 2 study of a drug for severe diabetic neuropathy. While the study is on-going, a new drug becomes commercially available that may have equal or greater benefit to the subject. The investigator should do which of the following?
(A) Tell the subject about the new drug but discourage him from switching treatment until the study is completed.
(B) Withhold this information to avoid confusing the subject with other treatment options or alternatives.
(C) Give the subject comprehensive information about the new drug, including its side effects. Discuss the pros and cons of both investigational drug and commercially available drug and then allow the subject to decide whether to withdraw from the research to take the new drug.
(D) Don't tell the subject about the new drug since phycian have the right to try our new treatments with their new patients.
Answers: 3
Health, 21.06.2019 22:30
Aduty of the adult assigned to supervise a group of children is to a. check on the children at least every 20 minutes. b. keep the children within earshot. c. give the children a list of "don'ts" concerning behavior. d. conduct a name-to-face check when transitioning to the playground
Answers: 1
Health, 22.06.2019 22:10
You are awaiting the white blood cell differential results for a patient who presented with a ruptured appendix and peritonitis. which type of leukocyte do you expect to be most elevated over its normal value?
Answers: 2
Health, 22.06.2019 23:00
Which of the following choices are the fat soluble vitamin? a) c b) b6 c) d d) calcium
Answers: 1
Health, 23.06.2019 05:00
Compare germany’s culture and food to america’s culture and food.
Answers: 1
A 46-year-old man is currently enrolled in a Phase 2 study of a drug for severe diabetic neuropathy....
Mathematics, 01.07.2019 10:30
History, 01.07.2019 10:30
History, 01.07.2019 10:30
Biology, 01.07.2019 10:30
Mathematics, 01.07.2019 10:30
History, 01.07.2019 10:30
Mathematics, 01.07.2019 10:30